Ideal Timing of Intrauterine Contraception Insertion After Medical Management of First Trimester Incomplete Abortion
NCT05343546 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2076
Last updated 2022-04-25
Summary
Background: Unintended pregnancies continue to cause a public health threat in Low and Middle Income countries yet with restrictive abortion laws. Over 40% of these unintended pregnancies end up as unsafe abortions leading to significant maternal morbidity and mortality. With ovulation occurring between 5-10 days after first trimester abortion, 47% of the women conceive shortly afterwards yet nearly 50% of the women never return for follow up.
This study seeks to investigate effectiveness of early insertion of Intrauterine contraception (IUC) (within one week after medical Post abortion care (mPAC)) compared to Standard IUC insertion (between 2-4 weeks post PAC), in Uganda with the ultimate aim of increasing the uptake of IUC post 1st trimester medical management of incomplete abortion.
Hypothesis:
Null hypothesis: Early Insertion of IUC has higher expulsion rates and continued use than standard insertion after medical management among women with first trimester incomplete abortion at six months within a non-inferiority margin of 7.5%.
Alternate hypothesis: Early Insertion of IUC has similar expulsion rates and continued use as standard insertion after medical management among women with first trimester incomplete abortion at six months within a non-inferiority margin of 7.5%.
Methods: A Non-inferiority RCT of 2,076 participants will be conducted in 15 health facilities within Central Uganda. Baseline participant characteristics will be analyzed using descriptive statistics. For continuous variables, statistical tests such as Fisher's exact test, t-test, ANOVA and Wilcoxon-Mann-Whitney test will be used as appropriate. Binary logistic regression model will be used for factors associated with the dependent variable uptake of intrauterine contraception with p-value set \<0.05 as level of significance. Intention to treat and per protocol analysis will be used for the RCTs.
Study utility: A greater proportion of women undergoing medical post abortion care for incomplete abortion will receive their intended post abortion IUC within the first days after the PAC treatment compared with routine insertion at a scheduled follow up visit 2-4 weeks later. Though there could be higher expulsion rates in the early versus the standard IUC insertion, continued use at 6 months following abortion will be higher in the early insertion group as compared to the standard insertion group thereby reducing unplanned and unwanted pregnancy.
Conditions
- Incomplete Abortion
- Intrauterine Contraception
- Misoprostol
Interventions
- DEVICE
-
Use of either copper T380A or Levonorgestrel LNG 52 IUS after medical management of first trimester incomplete abortion
Use of either copper T380A or Levonorgestrel LNG 52 IUS after medical management of first trimester incomplete abortion within seven days of giving Misoprostol "Early insertion" or 2-4 weeks after Misoprostol use "Standard insertion"
Sponsors & Collaborators
- collaborator OTHER
-
Makerere University
lead OTHER
Principal Investigators
-
Herbert Kayiga, MD, MPH · Makerere University College of Health Sciences
-
Kristina Gemzell-Danielsson, MD, PhD · Karolinska Institutet and Karolinska University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Max Age
- 49 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-30
- Primary Completion
- 2024-06-30
- Completion
- 2025-06-30
Countries
- Uganda
Study Locations
More Related Trials
-
Immediate vs. Delayed Insertion of Copper T 380A IUD After Termination of Pregnancy Over 12-weeks Gestation
NCT00540046 ·Status: COMPLETED ·Phase: NA
-
Immediate Versus Later Insertion of IUD After Medical Termination of Pregnancy
NCT01755715 ·Status: COMPLETED ·Phase: NA
-
Intrauterine Contraception After First Trimester Abortion - Effects on Quality of Life and Risk of Repeat Abortion.
NCT01223521 ·Status: COMPLETED ·Phase: NA
-
Trial of Immediate Versus Delayed Initiation of Transdermal Hormonal Contraception After Therapeutic Abortion
NCT00235547 ·Status: COMPLETED ·Phase: NA
-
Misoprostol Treatment of Mid Trimester Incomplete Abortion by Midwives and Doctors in Uganda.
NCT03622073 ·Status: COMPLETED ·Phase: NA
-
Misoprostol Treatment of Incomplete Abortion by Midwives and Physicians in Uganda
NCT01743508 ·Status: COMPLETED ·Phase: NA
-
Task Sharing to Improve Post Abortion Care at District Health Care Level- Trial in Uganda
NCT01844024 ·Status: COMPLETED ·Phase: PHASE4
-
Immediate Versus Delayed Insertion of the Copper Intrauterine Device (IUD) After Medication Abortion
NCT00737178 ·Status: COMPLETED ·Phase: PHASE4
-
Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After Abortion
NCT01958684 ·Status: COMPLETED
-
Immediate Versus Delayed Insertion of Intrauterine Contraception After Medical Abortion
NCT03603145 ·Status: UNKNOWN ·Phase: PHASE3
-
Intra Uterine Device Insertion in Nulliparous Women
NCT01422226 ·Status: TERMINATED ·Phase: NA
-
Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women
NCT00886834 ·Status: COMPLETED ·Phase: NA
-
Study of Immediate Start of Progestin Contraceptives in Medical Abortion
NCT01902485 ·Status: COMPLETED ·Phase: PHASE4
-
Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP)
NCT00957346 ·Status: TERMINATED ·Phase: PHASE3
-
The Extended Gestational Age Medical Abortion Study
NCT00997347 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Contraceptive Pills Versus Expectant Management for Retained Pregnancy Products
NCT03230825 ·Status: UNKNOWN ·Phase: NA
-
Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation
NCT02314754 ·Status: COMPLETED ·Phase: PHASE4
-
Misoprostol Prior to Intrauterine Contraceptive Device Insertion
NCT02412033 ·Status: COMPLETED ·Phase: PHASE1
-
Use of Misoprostol for Intrauterine Device (IUD) Insertion in Nulliparous Women
NCT01001897 ·Status: COMPLETED ·Phase: NA
-
Misoprostol for Preventing Postpartum Hemorrhage
NCT00124540 ·Status: COMPLETED ·Phase: NA
-
Midlevel Versus Physician-provided Medical Abortion in the Second Trimester
NCT04181541 ·Status: COMPLETED ·Phase: NA
-
Cervical Preparation of Abortions Under Paracervical Block in the First Trimester:
NCT03043014 ·Status: COMPLETED ·Phase: NA
-
Mifepristone and Mid-Trimester Termination of Pregnancy
NCT00382538 ·Status: COMPLETED ·Phase: NA
-
Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion
NCT00466999 ·Status: COMPLETED ·Phase: NA
-
Dilation and Curettage Versus Operative Hysteroscopy for Missed Abortion
NCT04705324 ·Status: UNKNOWN ·Phase: NA